-+ 0.00%
-+ 0.00%
-+ 0.00%

NRX PHARMACEUTICALS: WILL USE CLINICAL TRIAL DATA IN HAND WITH PROPOSED REAL WORLD DATA FROM OSMIND TO APPLY FOR NRX-100 APPROVAL

Reuters·02/17/2026 12:00:05

Please log in to view news